Errors in Abstract and Figure | JAMA Network Open | JAMA Network
[Skip to Navigation]
Sign In
Views 269
Citations 0
Correction
February 9, 2021

Errors in Abstract and Figure

JAMA Netw Open. 2021;4(2):e210700. doi:10.1001/jamanetworkopen.2021.0700

In the Original Investigation titled “Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial,”1 published October 19, 2020, there were errors in the Abstract and Figure 3B. The Abstract incorrectly described the results of the Multicenter Study of Oxaliplatin/5FU-LV in the Adjuvant Treatment of Colon Cancer trial as the results of the Bevacizumab-Avastin Adjuvant trial. In Figure 3B, the key reversed the colors for patients with favorable high-risk factors and those with multiple high-risk factors. This article has been corrected.1

References
1.
Chibaudel  B, Henriques  J, Rakez  M,  et al.  Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: a secondary analysis of the AVANT Trial.   JAMA Netw Open. 2020;3(10):e2020425. doi:10.1001/jamanetworkopen.2020.20425PubMedGoogle Scholar
×